©The Author(s) 2018.
World J Diabetes. Jan 15, 2018; 9(1): 1-24
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.1
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.1
Table 7 Differential diagnosis of diabetic neuropathies[39]
| Metabolic disease | Thyroid disease (common) |
| Renal disease | |
| Systemic disease | Systemic vasculitis |
| Nonsystemic vasculitis | |
| Paraproteinemia (common) | |
| Amyloidosis | |
| Infectious | Human immunodeficiency virus |
| Hepatitis B | |
| Lyme | |
| Inflammatory | Chronic inflammatory demyelinating polyradiculoneuropathy |
| Nutritional | B12 |
| Postgastroplasty | |
| Pyridoxine | |
| Thiamine | |
| Tocopherol | |
| Industrial agents, drugs, and metals | |
| Industrial agents | |
| Acrylamide | |
| Organophosphorous agents | |
| Drugs | Alcohol |
| Amiodarone | |
| Colchicine | |
| Dapsone | |
| Vinka alkaloids | |
| Metals | Platinum |
| Taxol | |
| Arsenic | |
| Mercury | |
| Hereditary | Hereditary motor, sensory, and autonomic neuropathies |
- Citation: Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes 2018; 9(1): 1-24
- URL: https://www.wjgnet.com/1948-9358/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i1.1